Hyderabad Telangana, India

Jagan Mohan Reddy Sanapureddy

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Jagan Mohan Reddy Sanapureddy

Introduction

Jagan Mohan Reddy Sanapureddy is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for the preparation of important compounds. With a total of three patents to his name, his work has had a meaningful impact on the industry.

Latest Patents

One of his latest patents is titled "Process for the preparation of raltegravir." This invention provides a process for the preparation of a crystalline anhydrous compound of Formula (X). Furthermore, it relates to the use of this compound in the preparation of Raltegravir or its pharmaceutically acceptable salt. Another significant patent is "Process for the preparation of Dolutegravir." This invention details the process for preparing (R)-3-Amino-1-butanol (D)-tartarate and its conversion to Dolutegravir. It also presents an improved method for preparing Dolutegravir or its pharmaceutically acceptable salts.

Career Highlights

Jagan Mohan Reddy Sanapureddy is currently associated with Aurobindo Pharma Limited, a prominent player in the pharmaceutical industry. His work at Aurobindo Pharma has allowed him to focus on innovative drug development and process optimization.

Collaborations

He has collaborated with several professionals in his field, including Sivakumaran Meenakshisunderam and Shankar Reddy Budidet. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jagan Mohan Reddy Sanapureddy is a distinguished inventor whose work in pharmaceutical processes has led to valuable innovations. His contributions continue to influence the industry and enhance the development of essential medications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…